PAVMED INC (PAVM)

US70387R4039 - Common Stock

0.6561  +0.01 (+1.72%)

After market: 0.688 +0.03 (+4.86%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
500K380K
-24.00%
2.452M
545.26%
3.749M
52.90%
13.078M
248.84%
52.326M
300.11%
187.27M
257.89%
243.37M
29.96%
311.51M
28.00%
389.44M
25.02%
EBITDA
YoY % growth
-54.16M
-132.15%
-88.47M
-63.35%
-65.863M
25.55%
-48.348M
26.59%
-39.372M
18.57%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-54.39M
-132.93%
-90.93M
-67.18%
-68.795M
24.34%
-51.899M
24.56%
-38.757M
25.32%
-13.878M
64.19%
21.318M
253.61%
47.226M
121.53%
79.152M
67.60%
118.32M
49.48%
Operating Margin
-10,878.00%-23,928.95%-2,805.67%-1,384.34%-296.35%-26.52%11.38%19.41%25.41%30.38%
EPS
YoY % growth
-0.62
-6.90%
-4.23
-582.26%
-9.16
-116.55%
-6.00
34.52%
-1.48
75.26%
-0.52
65.29%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.58
67.88%
-0.36
86.37%
-0.33
72.57%
-0.33
-122.67%
-0.17
70.18%
Revenue
Q2Q % growth
1M
-4.71%
735.42K
-27.19%
801.72K
-18.11%
1.25M
25.50%
2.55M
155.10%
EBITDA
Q2Q % growth
-11.118M
17.34%
-10.404M
22.65%
-10.302M
19.47%
-10.2M
2.38%
-8.466M
23.85%
EBIT
Q2Q % growth
-10.658M
34.95%
-10.102M
28.03%
-9.983M
27.05%
-9.929M
14.25%
-8.13M
23.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.44
160.00%
2.01-0.57-28.52%
Q2 2024
Q2Q % growth
-1.19
43.33%
-1.480.2919.72%
Q1 2024
Q2Q % growth
-2.62
8.07%
-1.71-0.91-53.50%
Q4 2023
Q2Q % growth
-1.81
47.54%
-1.930.126.11%
Q3 2023
Q2Q % growth
-2.40
-727.59%
-2.09-0.31-14.77%
Q2 2023
Q2Q % growth
-2.10
-624.14%
-2.910.8127.76%
Q1 2023
Q2Q % growth
-2.85
-1,325.00%
-3.160.319.87%
Q4 2022
Q2Q % growth
-3.45
-1,625.00%
-3.880.4310.99%
Q3 2022
Q2Q % growth
-0.29
-93.33%
-0.27-0.02-7.29%
Q2 2022
Q2Q % growth
-0.29
-107.14%
-0.23-0.06-23.61%
Q1 2022
Q2Q % growth
-0.20
-53.85%
-0.200.00-0.55%
Q4 2021
Q2Q % growth
-0.20
-17.65%
-0.15-0.05-30.72%
Q3 2021
Q2Q % growth
-0.15
-36.36%
-0.13-0.02-13.12%
Q2 2021
Q2Q % growth
-0.14
17.65%
-0.10-0.04-40.77%
Q1 2021
Q2Q % growth
-0.13 -0.12-0.01-6.21%
Q4 2020
Q2Q % growth
-0.17
10.53%
-0.12-0.05-47.06%
Q3 2020
Q2Q % growth
-0.11
-57.14%
-0.110.00-2.71%
Q2 2020
Q2Q % growth
-0.17
-70.00%
-0.10-0.07-66.67%
Q1 2020
Q2Q % growth
-0.13
-18.18%
-0.11-0.02-15.86%
Q4 2019
Q2Q % growth
-0.19
-26.67%
-0.11-0.08-69.34%
Q3 2019
Q2Q % growth
-0.07
41.67%
-0.100.0331.37%
Q2 2019
Q2Q % growth
-0.10
62.96%
-0.130.0324.59%
Q1 2019
Q2Q % growth
-0.11 -0.130.0217.04%
Q4 2018
Q2Q % growth
-0.15 -0.14-0.01-5.04%
Q3 2018
Q2Q % growth
-0.12 -0.120.001.96%
Q2 2018
Q2Q % growth
-0.27 -0.11-0.16-140.64%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
996K
25.92%
1.115M-119K-10.67%
Q2 2024
Q2Q % growth
979K
489.76%
1.228M-249K-20.28%
Q1 2024
Q2Q % growth
1.01M
126.46%
1.074M-64K-5.96%
Q4 2023
Q2Q % growth
1.049M
853.64%
1.069M-20K-1.87%
Q3 2023
Q2Q % growth
791K
888.75%
671.16K119.84K17.86%
Q2 2023
Q2Q % growth
166K 535.5K-369.5K-69.00%
Q1 2023
Q2Q % growth
446K
134.74%
408K38K9.31%
Q4 2022
Q2Q % growth
110K
-63.33%
280.5K-170.5K-60.78%
Q3 2022
Q2Q % growth
80K
-60.00%
237.997K-157.997K-66.39%
Q2 2022
Q2Q % growth
267.75K-267.75K-100.00%
Q1 2022
Q2Q % growth
190K 357K-167K-46.78%
Q4 2021
Q2Q % growth
300K 527.003K-227.003K-43.07%
Q3 2021
Q2Q % growth
200K 280.5K-80.5K-28.70%
Q2 2021
Q2Q % growth
173.4K-173.4K-100.00%
Q1 2021
Q2Q % growth
33.997K-33.997K-100.00%
Q2 2020
Q2Q % growth
1.326M-1.326M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS9.52% 55.12% 0% 0.59%
Revenue0% -51.29% -10.48% -22.41%